Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications

被引:1220
作者
Mangoni, AA
Jackson, SHD
机构
[1] Kings Coll Hosp Dulwich, Guys Kings & St Thomas Sch Med, Dept Hlth Care Elderly, London SE22 8PT, England
[2] Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Hlth Care Elderly, London, England
关键词
ageing; pharmacodynamics; pharmacokinetics;
D O I
10.1046/j.1365-2125.2003.02007.x
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Advancing age is characterized by impairment in the function of the many regulatory processes that provide functional integration between cells and organs. Therefore, there may be a failure to maintain homeostasis under conditions of physiological stress. The reduced homeostatic ability affects different regulatory systems in different subjects, thus explaining at least partly the increased interindividual variability occurring as people get older. important pharmacokinetic and pharmacodynamic changes occur with advancing age. Pharmacokinetic changes include a reduction in renal and hepatic clearance and an increase in volume of distribution of lipid soluble drugs (hence prolongation of elimination half-life) whereas pharmacodynamic changes involve altered (usually increased) sensitivity to several classes of drugs such as anticoagulants, cardiovascular and psychotropic drugs. This review focuses on the main age-related physiological changes affecting different organ systems and their implications for pharmacokinetics and pharmacodynamics of drugs.
引用
收藏
页码:6 / 14
页数:9
相关论文
共 120 条
[1]
Aging liver [J].
Anantharaju, A ;
Feller, A ;
Chedid, A .
GERONTOLOGY, 2002, 48 (06) :343-353
[2]
THE INFLUENCE OF AGE ON RENAL AND EXTRARENAL EFFECTS OF FRUSEMIDE [J].
ANDREASEN, F ;
HANSEN, U ;
HUSTED, SE ;
MOGENSEN, CE ;
PEDERSEN, EB .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (01) :65-74
[4]
Changes in plasma protein binding have little clinical relevance [J].
Benet, LZ ;
Hoener, BA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) :115-121
[5]
Bhantumnavin K, 1977, HDB BIOL AGEING, P709
[6]
Blechman MB, 1999, CLIN GERIATR MED, V15, P429
[7]
PHARMACOKINETIC OPTIMIZATION OF ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR THERAPY [J].
BURNIER, M ;
BIOLLAZ, J .
CLINICAL PHARMACOKINETICS, 1992, 22 (05) :375-384
[8]
INCREASED SENSITIVITY TO NITRAZEPAM IN OLD-AGE [J].
CASTLEDEN, CM ;
GEORGE, CF ;
MARCER, D ;
HALLETT, C .
BRITISH MEDICAL JOURNAL, 1977, 1 (6052) :10-12
[9]
EFFECT OF AGE ON PLASMA-LEVELS OF PROPRANOLOL AND PRACTOLOL IN MAN [J].
CASTLEDEN, CM ;
KAYE, CM ;
PARSONS, RL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 2 (04) :303-306
[10]
EFFECT OF AGING ON THE HEPATIC CLEARANCE OF PROPRANOLOL [J].
CASTLEDEN, CM ;
GEORGE, CF .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 (01) :49-54